Although healthcare providers face many regulatory challenges, opportunities exist for providers to benefit from substantial savings in the purchase of outpatient drugs. The federal 340B Drug Pricing Program allows many of our clients to realize valuable savings that further their ability to serve needy patients.
Husch Blackwell’s team has a deep understanding of all facets of the complicated healthcare industry. This in-depth knowledge allows us to routinely handle “mission-critical” matters for 340B clients such as federally qualified health centers, disproportionate share hospitals, critical access hospitals, children’s hospitals, specialized clinics and contract pharmacies.
We offer comprehensive advice and have extensive experience in the following areas: